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Abstract
Background: Multiple Sclerosis (MS) is primarily a disease of women in their childbearing years. Pregnancy and
puerperium have opposite effects on the course of the disease. Nevertheless, no studies have been carried out yet
on the level of information among female MS-patients regarding the interaction between MS and pregnancy.
Findings: Demographic data, clinical features of MS, course of MS during pregnancy and puerperium as well as
knowledge concerning MS and pregnancy were evaluated by means of a questionnaire in 154 female MS-patients.
The level of information was significantly higher (p < 0.001) in women who had been pregnant in the past with
the diagnosis MS known at this point of time. Furthermore patients reported about a lower frequency of relapses
during pregnancy and a higher frequency of relapses in the first six months after giving birth.
Conclusions: The findings illustrate a lack of knowledge in female MS-patients concerning the interactions of MS
and pregnancy. In order to make their own independent decision based on scientific facts known to date, female
MS-patients need to be better informed on issues regarding MS and pregnancy.
Introduction
Multiple Sclerosis (MS) is a chronic autoimmune disease
of the central nervous system (CNS). It primarily affects
premenopausal women [1,2]. Several studies show, that
pregnancy in MS-patients is associated with a lower risk of
progression and a lower risk of exacerbation, whereas the
relapse rate increases during the first three months post
partum [3-6]. There is no effect of pregnancy on the life-
time course of the disease and long term disability [4,6].
However, it has not been studied yet, to what extent
patients know about the interactions between pregnancy
and MS and how patients perceive the course of the dis-
ease during and after pregnancy. Thus our aims were two-
fold: 1) to investigate how patients perceive the course of
the disease during and after pregnancy and 2) to evaluate
the level of knowledge regarding MS and pregnancy.
Methods
Survey sample
Prior to conducting the study, the University of Luebeck
Ethics Committee approved the study and the question-
naire. The questionnaire was mailed to 300 women with
definitive MS who had been in contact with the Depart-
ment of Neurology of the University of Luebeck in the
past. The study was carried out November 06 - June 07,
age of the patients was 18-56 years. Additionally to the
questionnaire, the patients were provided a pre-
addressed, pre-stamped envelope and were instructed to
return their completed questionnaire with no further
identifying information.
Questionnaire design
A questionnaire based survey was designed to gather
data on the following in female MS-patients:
1) general demography, course of disease and medical
treatment,
2) perceived course of MS during and after pregnancy;
3) knowledge and personal beliefs regarding:
 a possible effect of MS on pregnancy
 a possible effect of pregnancy on MS
 a possible effect of the puerperium on MS
 a possible effect of breastfeeding on MS
The questionnaire used was a 7 page 31 item survey,
the language was German [Additional file 1]. The ques-
tionnaire can be requested from the authors.
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Analyses were conducted using statistical software (SPSS
vs.14 for windows). Data are presented as summary sta-
tistics (mean and median as appropriate). Ordered cate-
gorical data were summarized as proportions.
Significance was set at the 95% level.
Results
154 questionnaires were returned (response rate 51.3%).
Data from 150 patients could be analyzed. However,
since several questions were not answered by all partici-
pants of the study, the sample-size varies for single
questions.
General demography, course of disease, medical
treatment and walking ability
Mean age was 39.3 years, median 40, SD 9. Of 147
female MS-patients, 90 women (61.2%) experienced a
relapsing remitting (RR) course of MS, 20 women
(13.6%) a secondary progressive (SP) and 6 women
(4.1%) a primary progressive (PP) course of MS. 31
patients (21.1%) were not sure about their course of MS.
92 of 149 patients (61.7%) were treated with an immu-
nomodulatory or immunosuppressive agent.
Perceived course of MS during and after pregnancy
94 (62.7%) of 150 women had at least one child. In 36
women (24%) the diagnosis MS was known at the time
of their last pregnancy. 35 of these women rated the
course of MS and the relapse rate during pregnancy. 26
women of this subgroup (74%) experienced a lower
relapse rate during pregnancy, whereas nine women
(26%) reported about a relapse rate during pregnancy
that was as high or higher compared to the same period
of time before pregnancy. Of 35 women 21 patients
(60%) reported about a higher relapse rate for the first
six months after giving birth compared to the period of
pregnancy, six patients (17%) experienced no difference
in the relapse rate and four patients (11.5%) reported
about a lower relapse rate during this period of time.
For four women (11.5%) this period of time was not
over yet.
Level of knowledge regarding MS and Pregnancy
Four questions concerning MS and pregnancy were
asked using multiple-choice. Four possible answers to
each question were given, one of which was correct. Of a
total of 146 patients, only seven patients (4.8%) gave cor-
rect answers to all four questions. 17 patients (11.6%)
answered 3 questions, and 35 patients (24%) answered 2
questions correctly. One correct answer was given by 38
patients (26%) and 49 patients (33.6%) could give none
correct answer. We divided the group of MS-patients
who were pregnant at least once (n = 94) in a subgroup
of women without the diagnosis MS at the point of time
of their last pregnancy (n = 58; 61.7%), and in a subgroup
of patients with the definite diagnosis MS at the time of
their last pregnancy (n = 36; 38.3%; see (Figure 1). The
level of knowledge concerning issues related to MS and
pregnancy in the group of patients with the diagnosis MS
at the time of their last pregnancy was significantly
higher (p < 0.001, chi-square-test).
Discussion
Based on the patients’ answers, the rate of relapses
decreases during pregnancy, whereas there is a higher
rate of relapses for the first six months after giving
birth. These data are consistent with results of former
clinical studies, [4-6]. The extension of previous knowl-
edge consists of the fact, that the opposite effects of
pregnancy and puerperium are perceived by patients on
a subjective level as well. The underlying pathophysiolo-
gical mechanisms are not fully understood yet. Preg-
n a n c yl e a d st oaw i d er a n g eo fd i f f e r e n tp h y s i o l o g i c a l
changes, including the immune system [7]. In particular
a shift in the cytokine profile of pregnant women, from
a Th1 towards Th2 cytokine profile seems to play an
important role [8-10]. Other hormonal and immunologi-
cal changes are under discussion [11,12]. Particularly
with regard to possible therapeutic options in the future,
these mechanisms are currently in the focus of interest
[13-17]. However, our study has limitations, one of
which is the sample szize. Of 154 patients, only 35
women have been pregnant in the past with the diagno-
sis MS known at this point of time. The second aim of
our study was, to evaluate the level of information
among female MS-patients concerning MS and preg-
nancy. This level was surprisingly low. Nevertheless, it
has to be taken into consideration, that the age range of
subjects is broad and that views on reproduction of MS
have changed over time. However, there was one sub-
group of patients who was significantly better informed.
This group consisted of women who met two condi-
tions. First, these women were at least pregnant once
before, and second, the diagnosis MS was known at this
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Figure 1 Percentage of correct answers in female MS-patients
who have been pregnant in the past.
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Page 2 of 3point of time. Therefore we suggest, that the higher
level of knowledge in this group of patients is due to
their own experience. In view of these results we believe
that although there are various means of information
today for patients (Internet, booklets, TV etc.) physi-
cians need to provide actively, specifically and personally
information on the interactions of pregnancy and multi-
ple sclerosis to female MS-patients.
Additional file 1: Questionnaire multiple sclerosis and pregnancy.
This file contains the original questionnaire, that was mailed to the
female MS-patients. The language is German.
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